ABSTRACT-Itopride is a gastroprokinetic benzamide derivative. This agent inhibited both electric eel acetylcholinesterase (AChE) and horse serum butyrylcholinesterase (BuChE). The IC50 of itopride with AChE (2.04±0.27 pM) was, however, 100-fold less than that with BuChE, whereas in the case of neostigmine with AChE (11.3±3.4 nM), it was 10-fold less. The recovery of AChE activity inhibited by 10-7 M neostigmine was partial, but that inhibited by upto 3 x 10-5 M itopride was complete when the reaction mix ture was subjected to ultrafiltration. Double reciprocal plots of the experimental data showed that both Km and Vmax were affected by itopride, suggesting that the inhibition is a "mixed" type, although primarily being an uncompetitive one. The inhibitory effect of itopride on cholinesterase (ChE) activity in guinea pig gastrointestine was much weaker than that on pure AChE. However, in the presence of a low dose of diisopropyl fluorophosphate, just enough to inhibit BuChE but not AChE, the IC50s of itopride against ChE activities were found to be about 0.5 1tM. In conclusion, itopride exerts reversible and a "mixed" type of inhibition preferably against AChE. The IC50 of itopride for electric eel and guinea pig gastrointestinal AChE inhibition was 200 times and 50 times as large as that of neostigmine, respectively.
Itopride hydrochloride, N-[p-[2-(dimethylamino)eth oxy]benzyl]veratramide hydrochloride, is a newly synthe sized gastroprokinetic agent with a benzamide structure. In conscious dogs, itopride stimulates gastric motility and enhances acetylcholine (ACh)-induced gastric contraction (1). In in vitro studies, itopride dose-dependently inhibits the electric eel acetylcholinesterase (AChE) activity (1). Itopride enhances ACh-induced contraction of guinea pig ileum, but not carbachol-induced contraction (2). Sakaguchi et al. reported that AChE inhibition by some newly synthesized benzamide derivatives, including itopride, is closely related to the contractile response of the ileum (3) . AChE inhibitors stimulate gastrointestinal motor activity, and neostigmine has been used to treat in testinal paresis. Thus AChE inhibition by itopride may be responsible for the in vivo gastric stimulation of itopride. This study was conducted to: 1) demonstrate the inhibi tion properties of itopride against AChE, 2) demonstrate the inhibitory effect of itopride on crude cholinesterase (ChE) from the gastrointestinal tract and 3) examine the effects of itopride on ACh-induced contraction in guinea pig stomach at concentrations at which itopride inhibits AChE activity.
MATERIALS AND METHODS

Effect of itopride on ChE activity
Preparation of crude ChE from guinea pig gastrointes tine: Male Hartley guinea pigs, weighing 384-602 g, were sacrificed; and the whole stomach, a 10-cm portion of the jejunum, approximately 2 cm distal to the Treitz liga ment, and a 10-cm portion of the distal colon were quick ly dissected out and used. The stomach was opened along the greater curvature and the jejunum and colon, along the mesenteric border. The organs were then rinsed in ice cold 0.32 M sucrose, and fat and mucosa were removed from the smooth muscle layer. These smooth muscle preparations were then separately weighed and well minced with scissors. The minced tissues suspended in 3 volumes of 0.32 M sucrose were homogenized twice for 20 sec each with a homogenizer (Polytron PT10-35; Kinematica, Luzern, Switzerland) set at speed level 8 and then centrifuged at 10,300 x g for 10 min at 41C. The su pernatant fractions were recentrifuged at 164,600 x g for 30 min in an ultracentrifuge (70P-72; Hitachi, Tokyo). The final supernatant and precipitate fractions thus ob tained served as crude ChE preparations, which were kept frozen until use. The protein content of the crude ChE was measured by the dye method (4) .
Assay of ChE activity: ChE activity was measured at 301C and pH 8.5 by the photometric method of Ellman et al. (5) . The reaction mixture contained 2.76 ml of 0.1 M Tris-HCl buffer (pH 8.5), 0.10 ml of 0.1 M 5,5'-dithio bis(2-nitrobenzoic acid) (DTNB) and 0.10 ml of either itopride, neostigmine or Tris-HCI buffer (as a control). Twenty microliters of AChE (7.5 units/ml), BuChE (7.5 units/ml) or the crude ChE (2.25 7.75 mg protein/ml) was then added to the reaction mixtures containing itopride or neostigmine. In the preliminary study, inhibi tion by itopride was independent of preincubation time, while that by neostigmine reached a steady state after a preincubation of 20 min or more. Itopride and neostig mine containing mixtures were preincubated at 30°C for 3 and 30 min, respectively. To initiate the reaction, 20 pl of the substrate (final concentration of 5.0 x 10-4 M) was ad ded to the reaction mixture. The ChE activity of crude tis sue preparations was measured in the presence and ab sence of 1 x 10-8 M diisopropyl fluorophosphate (DFP). Acetylthiocholine (ATCh) was used as a specific substrate for AChE and ChE, and butyrylthiocholine (BuTCh) was used for BuChE. ATCh was also used as a substrate of crude ChE. To elucidate the type of AChE inhibition by itopride, AChE activity was measured at increasing ATCh concentrations. ChE activity was determined by measuring the change in absorbance at 412 nm for 2 min with a spectrophotometer (U-2000, Hitachi). Enzyme activity was expressed as increase in absorbance per minute.
Reversibility of AChE inhibition by itopride, neostig mine and DFP: Reversibility of AChE inhibition by itopride, neostigmine and DFP was assessed by a repeated ultrafiltration. The sample mixtures containing 3.70 ml of 0.1 M Tris-HCI buffer, 133 pl of 10 mM DTNB, 133 pl of test material (or Tris-HCI buffer as a control) and 26.7 p1 of AChE (7.5 units/ml) were preincubated for 30 min at 30'C. Each mixture was then divided into 2 equal por tions. One portion was used for AChE assay by adding 26.7 pl of ATCh. The enzyme assay value was compared with that of the control mixture without inhibitors to de termine the original inhibitor activity. To examine the reversibility of the AChE inhibition by drugs, we applied repeated ultrafiltration and dilution for dialysis to remove the drug from AChE in the sample mixtures. Thus, the other half of the mixture was concentrated in an ultra filtration device (Centricon-30; Amicon, Beverly, MA, USA) by centrifugation (SCR20BA, Hitachi) at 1,000 x g for 60 min at 4C. The concentrate was diluted with 2.0 ml Tris-HCI buffer. The ultrafiltration and dilution were repeated twice following the same protocol. The final con centrate was diluted with 2.0 ml Tris-HCl buffer contain ing 3.33 x 10_4 M DTNB, and its AChE activity was meas ured as described above.
Effects of itopride and neostigmine on ACh-induced con traction in isolated guinea pig stomach
The guinea pig stomach was opened along the greater curvature, and the mucosa was carefully removed from the muscle layer with scissors. Circular muscle prepara tions of the gastric body about 2 mm in width and 10 mm in length were obtained by cutting along the circular axis. Each preparation was suspended in an organ bath contain ing Tyrode solution (pH 7.4, 371C) consisting of 137.9 mM NaCI, 2.7 mM KCI, 1.8 mM CaC12, 0.5 mM MgC12, 1.1 mM NaH2PO4, 11.9 mM NaHCO3 and 5.6 mM glu cose. The Tyrode solution was bubbled with room air. The stomach was subjected to an initial tension of 1.0 g. ACh was cumulatively added, and the tension was record ed isometrically by using a force displacement transducer (TB-612T; Nihon Kohden, Tokyo). Dose-response curves for ACh were obtained in the presence or absence of itopride or neostigmine. The contractile response was ex pressed as a percentage of the maximum response on the dose-response curves without itopride or neostigmine.
Drugs
Acetylthiocholine iodide was purchased from Nacalai Tesque (Kyoto) or Sigma Chemicals (St. Louis, MO, USA).
Butyrylthiocholine iodide and neostigmine bromide were from Nacalai Tesque. Pure acetyl cholinesterase (EC3.1.1.7, electric eel) and butyryl cholinesterase (EC3.1.1.8, horse serum) were purchased from Sigma Chemicals. Diisopropyl fluorophosphate and 5,5 dithio-bis(2-nitrobenzoic acid) were from Wako Pure Chemical Industries (Tokyo). Acetylcholine chloride was purchased from Daiichi Seiyaku (Tokyo). Itopride hydrochloride was synthesized by Hokuriku Seiyaku Co., Ltd.
Data analysis
IC50s of itopride and neostigmine were graphically determined from the 50% inhibition levels in the dose response curves. All data are expressed as means±S.E.M.
Statistical significance was examined by Student's t-test. A difference was considered significant at P <0.05.
RESULTS
Inhibition of ChE activity by itopride
To characterize the inhibition of ChE activity by itopride, its inhibitory effect on electric eel AChE was compared with that on horse serum BuChE. Itopride in hibited AChE and BuChE activity dose-dependently (Fig. 1) . Inhibitory action on AChE was about 100 times stronger than that on BuChE (AChE: IC50=2.04±0.27 pM, BuChE: IC50=252±20 tzM). Neostigmine inhibited AChE (IC50 =11.3 ± 3.4 nM) more potently than BuChE (IC50=120± 15 nM). The IC50 ratio between AChE and BuChE for itopride was 10.5 times as large as that for neostigmine, suggesting greater selectivity of itopride than neostigmine toward AChE.
The reversibility of AChE inhibition by itopride was compared with that by neostigmine and DFP. Submax imal inhibition occurred at 3 x 10-5 M for itopride, 1 x 10-7 M for neostigmine and 1 x 10-5 M for DFP (Table  1) . Itopride-induced AChE inhibition was completely abolished by dialysis, whereas that caused by neostigmine decreased to a half; and as far as DFP is concerned, there was only a slight decrease in inhibition (Table 1 ). This clearly shows that itopride is a reversible AChE inhibitor.
To determine the type of AChE inhibition by itopride, saturation experiments with increasing substrate concen tration were carried out. Double reciprocal plots from the experimental data were linear at all itopride concentra tions (Fig. 2) . AChE inhibition in the presence of increas ing concentrations of itopride produced straight lines characterized by increasing slopes and intercepts on the 1 /V axis, although the slope variation was very small. Km and Vmax were thus affected by itopride. Inhibitory effects of itopride and neostigmine on crude ChE from guinea pig gastrointestine The effects of itopride and neostigmine on crude ChE activity obtained from three gastrointestinal sources, stomach, jejunum and colon, were examined. Figure 3 shows the inhibitory effects of itopride and neostigmine on each of the ChEs of the supernatant fractions from the three sources. Itopride inhibited the crude ChE activity in a dose-dependent manner, and the inhibitory action on the crude ChEs derived from the three organs was essen tially the same (Table 2 and Fig. 3 ). Inhibition by itopride of crude ChE was extremely weak compared to its electric eel AChE inhibition. Dose-response curves of itopride for crude ChE shifted to the left by 1 x 10-8 M DFP, and the IC50 of itopride in the presence of DFP for the three or gans was 300 600 times less than in the absence of DFP (Table 2 and Fig. 3 ). DFP inhibited BuChE activity dose dependently (data not shown), and 1 x 10-'M DFP almost completely inhibited BuChE (94.4±0.9%)
without AChE inhibition (3.6±0.8%). DFP (1 x 10-'M) could induce only a slight shift to the left in the neostig mine dose-response curve, whereas in the case of the itopride dose-response curve, DFP at the same concentra tion could induce a significant left shift (Table 2 and Fig.  3 ). This clearly shows that itopride selectively inhibits AChE in the gastrointestine. Effects of itopride and neostigmine on A Ch-induced con traction in isolated guinea pig stomach Figure 4 shows the enhancing effect of itopride and neostigmine on ACh-induced contraction in guinea pig stomach. Exogenously applied ACh produced stomach contraction dose-dependently, while 1 x 10-6 and 1 x 10-5 M itopride alone did not. ACh-induced contraction in the presence of itopride (1 x 10-6 and 1 x 10-5 M) was significantly greater than that in the absence of itopride, suggesting that itopride enhances the effect of ACh (Fig.  4) . Neostigmine (1 x 10-8 and 1 x 10-'M) enhanced the contractile response to ACh (Fig. 4) . The concentrations of itopride and neostigmine used were within the range of their effectiveness to inhibit AChE activity.
DISCUSSION
Itopride is a newly synthesized gastroprokinetic agent that was found to stimulate gastric emptying in dogs and rats and small intestinal transit in mice (6) . In conscious dogs, itopride stimulates postprandial gastric motility and enhances gastric contraction evoked by ACh infusion (1). Itopride inhibits electric eel AChE (IC50=2.9 pM) (1) and enhances guinea pig ileum contraction evoked by ACh (2) in vitro. These results suggest that AChE inhibition is in volved in the mechanism of the itopride-induced stimula tion of gastric motility in conscious dogs. Thus, in the present study, we further characterized the inhibitory ac tion of itopride on ChE activity. AChE, also known as true-ChE, is found in cholinergic neurons and is the enzyme that terminates the action of ACh at the junctions of cholinergic nerve endings. BuChE, so-called pseudo-ChE, is present not only in neuronal elements of the central and peripheral nervous system but also in plasma, erythrocytes, liver and other or gans. BuChE is able to hydrolyze ACh, but its physiologi cal function is not yet known. Itopride dose-dependently inhibited both AChE and BuChE. The IC50 of itopride for AChE inhibition was, however, 100 times lower than that for BuChE inhibition, demonstrating selective inhibi tion of AChE by the drug. Under the same experimental conditions, the IC50 of neostigmine for the inhibition of AChE was also lower when compared to that of BuChE. However, the IC50 ratio of neostigmine between AChE and BuChE was 10 times less than that with itopride. Atack et al. reported that the IC50 of neostigmine for AChE inhibition was about two times less that for BuChE inhibition (7) . Therefore, the higher selectivity towards AChE inhibition seems to be a unique characteris tic of itopride action. Atack et al. also reported that IC50s of DFP for the inhibition of AChE and BuChE were 76 nM and 0.2 nM, respectively (7) . These values are consis tent with the present study that 10 nM DFP completely in hibited BuChE activity without affecting AChE.
The double reciprocal plots as shown in Fig. 2 are very similar to that reported by Galli et al. (8) on the histamine H2-antagonist ranitidine. It was reported that the IC50 of ranitidine for AChE inhibition was 3.5 x 10-6 M; and at doses of 1 and 3 mg/kg/hr, ranitidine significantly en hanced ACh-induced gastric contractions in conscious dogs (9) , showing that ranitidine and itopride were equipotent in vitro and in vivo. Three classes of AChE in hibitors are known (10) . Quaternary compounds such as edrophonium inhibit the enzyme reversibly by combining with the active center. Drugs such as neostigmine possess ing a carbamyl ester linkage are hydrolyzed by AChE, but much more slowly than ACh. Organophosphorus inhibi tors such as DFP inhibit the enzyme irreversibly by serv ing as true hemisubstrates. Regarding their chemical struc tures, itopride and ranitidine differ from the three classes of AChE inhibitors. Accordingly, itopride and ranitidine are similar in some respects. Galli et al. conclude that the ranitidine action was a "mixed" type inhibition, as the double reciprocal plots of AChE inhibition by increasing concentrations of ranitidine gave straight lines character ized by increasing slopes and intercepts on the 1/V axis, although the slope variation was very small (8) . The inhibi tion of the "mixed" type contains characteristics common to both "competitive" and "non-competitive" inhibition and can occur when a reversible inhibitor combines with a free enzyme and the enzyme-substrate complex with differ ent affinities. In "mixed" type inhibition, Km and Vmax are affected by the drug. Aono et al. (11) also analyzed the ranitidine action on AChE and reached the same conclu sion on the type of inhibition as reported by Galli et al. (8) . Similar analysis of the present data may suggest that the itopride action is primarily an uncompetitive type inhi bition with only a small contribution of the competitive type interaction, especially in the higher concentration range.
The reversibility of AChE inhibition by itopride was compared with that of neostigmine and DFP. AChE inhi bition by itopride was almost completely abolished by di alysis. Inhibitory action of neostigmine on AChE was not as readily reversible as that of itopride. DFP is an irrever sible AChE inhibitor (12) , and AChE inhibition by DFP was confirmed to be irreversible in this study also.
AChE is a complex family of molecular forms (13, 14) . The most common forms are monomers, dimers and tetramers of the same subunit, plus an asymmetric form consisting of three tetramers covalently linked via di sulfide bonds to a three-stranded collagen-like tail. Tsim et al. reported asymmetric AChE to contain a hybrid of AChE and BuChE catalytic subunits linked to a common collagen-like tail (15) . The inhibitory potency of each of the various inhibitors toward AChEs differed according to the source of AChE (7). In the presence of 10 nM DFP, where BuChE activity was abolished, itopride showed selective inhibition of AChE. In isolated guinea pig stomach, itopride at 1 x 10-6 and 1 x 10-5 M enhanced ACh-induced contraction. This result shows that itopride enhances ACh-induced gastric contraction not through BuChE inhibition but through AChE inhibition. Adler et al. showed a competition between BuChE and AChE in the regulation of synaptically released ACh concentra tions in canine trachealis muscle, thus elucidating a func tional role for BuChE in this tissue (16) . In rabbit duo denum, however, the increase in tone produced by DFP appears to be due to AChE inhibition by the agent rather than BuChE (17) . The results of the present study and previous report (17) indicate that AChE may possibly be more important than BuChE in the gastrointestinal mo tor stimulation of ChE inhibitors.
It is evident from the present results that itopride exerts a selective and reversible AChE inhibition and enhances ACh-induced contraction in isolated guinea pig stomach.
